{
  "compound": "CBD-rich cannabis oil (THC:CBD 4%:15%)",
  "condition": "IBD_CROHNS",
  "effect_size": "Large (d = 0.78)",
  "study_type": "RCT",
  "source": "NORML:IBD_RCT_003",
  "participants": "56 patients with mild-moderate Crohn's disease",
  "year": 2021,
  "notes": "CBD-Rich Cannabis Oil for Crohn's Disease: Phase II Trial",
  "confidence": "medium",
  "abstract": "Cannabis oil: 65% remission vs Placebo: 35% (p=0.04); Significant CDAI reduction (mean -82 points)"
}